Partnerships: The way to Successful Antimalarial Development.

Abstract

This presentation describes the development of the new antimalarial formulations ASAQ (artemisinin + amodiaquine) and ASMQ (artesunate + mefloquine) by DNDi and its partners in the FACT project.

Citation

Presentation from symposium ‘Challenges and Successes of the FACT Project through Innovative Partnerships for the Development of Artesunate Combination Therapies for Malaria’, held at American Society of Tropical Medicine and Hygiene 59th Annual Meeting, Atlanta, Georgia, USA, 5 November 2010.

Partnerships: The way to Successful Antimalarial Development.

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.